NCT07130903
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07130903
Title Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Karmanos Cancer Institute at McLaren Bay Region RECRUITING Bay City Michigan 48706 United States Details
Karmanos Cancer Institute at McLaren Clarkston RECRUITING Clarkston Michigan 48346 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Karmanos Cancer Institute at McLaren Flint RECRUITING Flint Michigan 48532 United States Details
Karmanos Cancer Institute at McLaren Greater Lansing RECRUITING Lansing Michigan 48910 United States Details
Karmanos Cancer Institute at McLaren Lapeer Region RECRUITING Lapeer Michigan 48446 United States Details
Karmanos Cancer Institute at McLaren Macomb RECRUITING Macomb Michigan 48043 United States Details
Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey RECRUITING Petoskey Michigan 49770 United States Details
Karmanos Cancer Institute at McLaren Port Huron RECRUITING Port Huron Michigan 48060 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field